3,3'-OH curcumin causes apoptosis in HepG2 cells through ROS-mediated pathway

Area of Science:

• Medicinal Chemistry
• Cell Biology
• Biochemistry

Background:

• Curcumin, a natural compound, exhibits anticancer properties but suffers from poor stability and bioavailability.
• Developing more potent curcumin analogs is crucial for effective cancer therapy.
• Understanding the mechanisms of action, such as apoptosis induction, is key to drug design.

Purpose of the Study:

• To synthesize and evaluate novel curcumin analogs for cytotoxicity against HepG2 liver cancer cells.
• To investigate the role of the hydroxyl group at the 3,3'-position in anti-proliferative activity.
• To elucidate the mechanism of action of the most potent analog, focusing on reactive oxygen species (ROS) generation and apoptosis induction.

Main Methods:

• Synthesis of a series of curcumin analogs.
• Cytotoxicity assays using HepG2 cells.
• Analysis of ROS generation (hydroxyl radicals and H2O2).
• Assessment of cellular uptake and stability in RPMI-1640 medium.
• Evaluation of mitochondrial membrane potential and lipid peroxidation.

Main Results:

• The hydroxyl group at the 3,3'-position significantly enhanced anti-proliferative activity.
• 3,3'-hydroxy curcumin (1b) demonstrated superior cytotoxic activity and ROS-generating ability compared to curcumin.
• Compound 1b exhibited greater stability and cellular uptake in RPMI-1640 medium.
• ROS generation by 1b disrupted intracellular redox balance, induced lipid peroxidation, and caused mitochondrial dysfunction, leading to apoptosis.

Conclusions:

• 3,3'-hydroxy curcumin (1b) induces apoptosis in HepG2 cells via a ROS-mediated pathway.
• Enhanced stability and cellular uptake contribute to the increased efficacy of 1b.
• The findings provide valuable insights for the rational design of novel curcumin-based anticancer agents.